NAVB logo

Navidea Biopharmaceuticals (NAVB) Interest Expense

Annual Interest Expense

$1.10 M
+$1.09 M+17060.94%

31 December 2022

NAVB Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

N/A

30 September 2023

NAVB Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

N/A

30 September 2023

NAVB TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NAVB Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+10000.0%--
5 y5 years---

NAVB Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high>+9999.0%
5 y5 yearsat high>+9999.0%
alltimeall time-37.0%>+9999.0%

Navidea Biopharmaceuticals Interest Expense History

DateAnnualQuarterlyTTM
Mar 2023
-
$263.20 K(+7013.5%)
$263.20 K(+7013.5%)
Dec 2022
$1.10 M(>+9900.0%)
-
-
Mar 2022
-
$3700.00(+27.6%)
$3700.00(+27.6%)
Dec 2021
$6400.00(+30.6%)
-
-
Mar 2021
-
$2900.00(+20.8%)
$2900.00(+20.8%)
Mar 2020
-
$2400.00(-99.8%)
$2400.00(-99.9%)
Dec 2016
$4900.00(-99.6%)
-
-
Dec 2015
$1.27 M(+8.9%)
-
-
Sept 2013
-
$976.20 K(+109.8%)
$2.04 M(+47.9%)
June 2013
-
$465.30 K(+28.1%)
$1.38 M(+11.6%)
Mar 2013
-
$363.10 K(+53.9%)
$1.24 M(+5.9%)
Dec 2012
$1.17 M
$236.00 K(-25.2%)
$1.17 M(+24.0%)
Sept 2012
-
$315.30 K(-1.9%)
$940.50 K(+50.3%)
June 2012
-
$321.40 K(+9.4%)
$625.80 K(+104.8%)
DateAnnualQuarterlyTTM
Mar 2012
-
$293.70 K(+2807.9%)
$305.50 K(+2179.9%)
Dec 2011
$13.30 K(-97.6%)
$10.10 K(+1583.3%)
$13.40 K(+197.8%)
Sept 2011
-
$600.00(-45.5%)
$4500.00(-4.3%)
June 2011
-
$1100.00(-31.3%)
$4700.00(-98.3%)
Mar 2011
-
$1600.00(+33.3%)
$272.20 K(-51.0%)
Dec 2010
$555.00 K(-63.8%)
$1200.00(+50.0%)
$555.00 K(-33.7%)
Sept 2010
-
$800.00(-99.7%)
$837.30 K(-28.3%)
June 2010
-
$268.60 K(-5.6%)
$1.17 M(-14.2%)
Mar 2010
-
$284.40 K(+0.3%)
$1.36 M(-11.3%)
Dec 2009
$1.53 M(-12.1%)
$283.50 K(-14.3%)
$1.53 M(+22.7%)
Sept 2009
-
$330.80 K(-28.3%)
$1.25 M(+36.0%)
June 2009
-
$461.60 K(+1.0%)
$918.70 K(+101.0%)
Mar 2009
-
$457.10 K(+37.8%)
$457.10 K(+37.8%)
Dec 2008
$1.74 M
-
-
Mar 2008
-
$331.80 K
$331.80 K

FAQ

  • What is Navidea Biopharmaceuticals annual interest expense?
  • What is the all time high annual interest expense for Navidea Biopharmaceuticals?
  • What is the all time high quarterly interest expense for Navidea Biopharmaceuticals?
  • What is the all time high TTM interest expense for Navidea Biopharmaceuticals?

What is Navidea Biopharmaceuticals annual interest expense?

The current annual interest expense of NAVB is $1.10 M

What is the all time high annual interest expense for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high annual interest expense is $1.74 M

What is the all time high quarterly interest expense for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high quarterly interest expense is $976.20 K

What is the all time high TTM interest expense for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high TTM interest expense is $2.04 M